Status:
COMPLETED
Analgesic Efficacy of Erector Spinae Infusion Versus Thoracic Epidural for Patients With Upper Abdominal Cancer Surgeries
Lead Sponsor:
Assiut University
Conditions:
Pain Relief in Upper Abdominal Cancer Surgeries
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Epidural analgesia is considered by many to be the reference standard which has been shown to reduce the intraoperative surgical stress response. However, besides its excellent analgesic effect, ther...
Detailed Description
Surgical trauma activates numerous receptors leading to severe postoperative pain. Therefore, effective pain management is a priority of care and a patient right. Postoperative pain may cause tachyca...
Eligibility Criteria
Inclusion
- Patients subjected to major upper abdominal cancer surgery.
- The enrolled age will be from 18 years to 70 years
- ASA I-II and NYHA I-II.
Exclusion
- ASA physical status \>II, and NYHA \>II
- Patient refusal
- body mass index \>40 kg/m2
- preoperative opioid consumption
- a local infection at the incision site
- a history of hematological disorders or coagulation abnormality
- previous abdominal surgeries, severe hepatic or renal impairment
- Anomalies of vertebral column.
- Pregnant women
- Hypersensitivity to any of used drugs
- chronic pain
Key Trial Info
Start Date :
February 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04776109
Start Date
February 15 2021
End Date
December 11 2023
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 71511